{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:36Z","timestamp":1788871776749,"version":"build-2803163510"},"reference-count":42,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,5,8]]},"DOI":"10.3233\/jad-180059","type":"journal-article","created":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T11:38:24Z","timestamp":1525001904000},"page":"989-1002","source":"Crossref","is-referenced-by-count":30,"title":["Change of Amyloid-\u03b2 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal\u00a0Pressure Hydrocephalus"],"prefix":"10.1177","volume":"63","author":[{"given":"Chihiro","family":"Akiba","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Miyajima","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Ogino","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Motoi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Tokuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan"},{"name":"Department of Molecular Pathobiology of Brain Diseases, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Irie","sequence":"additional","affiliation":[{"name":"Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180059_ref1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM196507152730301","article-title":"Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure. A treatable syndrome","volume":"273","author":"Adams","year":"1965","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-180059_ref2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/WNL.55.4.576","article-title":"Three-year survival and functional outcome of patients with idiopathic adult hydrocephalus syndrome","volume":"55","author":"Malm","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-180059_ref3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/3-211-32318-X_49","article-title":"Three-year outcome of shunted idiopathic NPH patients","volume":"95","author":"Aygok","year":"2005","journal-title":"Acta Neurochir Suppl"},{"key":"10.3233\/JAD-180059_ref4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.22015","article-title":"Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology","volume":"68","author":"Hamilton","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-180059_ref5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/NEN.0000000000000191","article-title":"Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus","volume":"74","author":"Elobeid","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-180059_ref6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2377-14-66","article-title":"Evaluation of coexistence of Alzheimer\u2019s disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers","volume":"14","author":"Lim","year":"2014","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-180059_ref7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-9-7","article-title":"Phosphorylated tau\/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus","volume":"9","author":"Patel","year":"2012","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-180059_ref8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-170186","article-title":"Cerebrospinal fluid amyloid-\u03b2 42, total Tau and phosphorylated Tau are low in patients with normal pressure hydrocephalus: Analogies and differences with Alzheimer\u2019s disease","volume":"60","author":"Santangeloa","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180059_ref9","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.0000000000000916","article-title":"Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-180059_ref10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","article-title":"Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: A discrimination from Alzheimer\u2019s disease","volume":"14","author":"Kapaki","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-180059_ref11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12987-017-0062-5","article-title":"Cerebrospinal fluid A\u03b242, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: A systematic review and meta-analysis","volume":"14","author":"Chen","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-180059_ref12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jalz.2012.08.004","article-title":"Cerebrospinal fluid A\u03b242 is the best predictor of clinical progression in patients with subjective complaints","volume":"9","author":"van Harten","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180059_ref13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2015.07.001","article-title":"Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus","volume":"357","author":"Nakajima","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-180059_ref14","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from A\u03b21-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-180059_ref15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.3233\/JAD-180059_ref16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","article-title":"Clinical core of the Alzheimer\u2019s disease neuroimaging initiative: Progress and plans","volume":"6","author":"Aisen","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180059_ref17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-180059_ref18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cbic.200800411","article-title":"Identification of physiological and toxic conformations in A\u03b242 aggregates","volume":"10","author":"Masuda","year":"2009","journal-title":"ChemBioChem"},{"key":"10.3233\/JAD-180059_ref19","doi-asserted-by":"crossref","first-page":"52781","DOI":"10.1074\/jbc.M406262200","article-title":"Analysis of the secondary structure of \u03b2-amyloid (A\u03b242) fibrils by systematic proline replacement","volume":"279","author":"Morimoto","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-180059_ref20","doi-asserted-by":"crossref","first-page":"46179","DOI":"10.1074\/jbc.M301874200","article-title":"Neurotoxicity and physicochemical properties of A\u03b2 mutant peptides from cerebral amyloid angiopathy: Implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"278","author":"Murakami","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-180059_ref21","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/cn300033k","article-title":"Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of A\u03b242","volume":"3","author":"Izuo","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-180059_ref22","doi-asserted-by":"crossref","first-page":"431320","DOI":"10.4061\/2011\/431320","article-title":"E22\u0394 mutation in amyloid \u03b2-protein promotes \u03b2-sheet transformation, radical production, and synaptotoxicity, but not neurotoxicity","volume":"2011","author":"Suzuki","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-180059_ref23","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1038\/s41598-017-11671-6","article-title":"A toxic conformer of A\u03b242 with a turn at 22-23 is a novel therapeutic target for Alzheimer\u2019s disease","volume":"7","author":"Izuo","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180059_ref24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2176\/nmc.52.775","article-title":"Guidelines for management of idiopathic normal pressure hydrocephalus: Second edition","volume":"52","author":"Mori","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.3233\/JAD-180059_ref25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-180059_ref26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects. Predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-180059_ref27","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: A Frontal Assessment Battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-180059_ref28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.3233\/JAD-180059_ref29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.wneu.2014.08.004","article-title":"Use of external lumbar cerebrospinal fluid drainage and lumboperitoneal shunts with Strata NSC valves in idiopathic normal pressure hydrocephalus: A single-center experience","volume":"83","author":"Nakajima","year":"2015","journal-title":"World Neurosurg"},{"key":"10.3233\/JAD-180059_ref30","doi-asserted-by":"crossref","first-page":"29038","DOI":"10.1038\/srep29038","article-title":"Monoclonal antibody with conformational specificity for a toxic conformer of amyloid \u03b242 and its application toward the Alzheimer\u2019s disease diagnosis","volume":"6","author":"Murakami","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180059_ref31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.3233\/JAD-180059_ref32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-142622","article-title":"Idiopathic normal pressure hydrocephalus has a different cerebrpspinal fluid biomarker profile from Alzeheimer\u2019s disease","volume":"45","author":"Jingami","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180059_ref33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jpsychires.2010.07.011","article-title":"Biochemical studies in normal pressure hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (A\u03b2) peptide and phospho-tau","volume":"45","author":"Ray","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-180059_ref34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180059_ref35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180059_ref36","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","article-title":"Idiopathic normal-pressure hydrocephalus: Pathophysiology and diagnosis by CSF biomarkers","volume":"80","author":"Jeppsson","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-180059_ref37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-142862","article-title":"Amyloid-\u03b2 and tau dynamics in human brain interstitial fluid in patients with suspected normal pressure hydrocephalus","volume":"46","author":"Herukka","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180059_ref38","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1161591","article-title":"Amyloid-\u03b2 dynamics correlate with neurological status in the injured human brain","volume":"321","author":"Brody","year":"2008","journal-title":"Science"},{"key":"10.3233\/JAD-180059_ref39","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2011","journal-title":"Science"},{"key":"10.3233\/JAD-180059_ref40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease","volume":"41","author":"Gomez-Isla","year":"1997","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-180059_ref41","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/09168451.2014.940275","article-title":"Conformation-specific antibodies to target amyloid \u03b2 oligomers and their application to immunotherapy for Alzheimer\u2019s disease","volume":"78","author":"Murakami","year":"2014","journal-title":"Biosci Biotech Biochem"},{"key":"10.3233\/JAD-180059_ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2013.05.106","article-title":"Non-toxic conformer of amyloid \u03b2 may suppress amyloid \u03b2-induced toxicity in rat primary neurons: Implications for a novel therapeutic strategy for Alzheimer\u2019s disease","volume":"438","author":"Izuo","year":"2013","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:00Z","timestamp":1777370820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":42,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-180059","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]}}}